Form 4 for OPCH Option Care Health, Inc.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001437749-23-004599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-24 | 2023-02-22 | OPCH | SHAPIRO MICHAEL H. | CFO | A - Grant | $0.00 | +158.6K | 38.1K | New | $0 |
| D | 2023-02-24 | 2023-02-23 | OPCH | SHAPIRO MICHAEL H. | CFO | F - Tax | $31.90 | -2,421 | 176.9K | -1% | -$77.2K |
| DM | 2023-02-24 | 2023-02-22 | OPCH | SHAPIRO MICHAEL H. | CFO | A - Grant | $0.00 | +175.0K | 31.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | A | A | 63,264 | $0.00 | 179,339 | D | — | — | (F3) Represents shares of common stock issuable under a performance-based restricted stock unit award dated February 23, 2021. On February 22, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest on February 23, 2024, assuming continuous service on the vesting date. |
| 2 | Common | Common Stock | 2023-02-22 | A | A | 77,963 | $0.00 | 116,075 | D | — | — | (F2) All restricted stock units granted in this award vest on February 22, 2026. |
| 3 | Common | Common Stock | 2023-02-22 | A | A | 17,328 | $0.00 | 38,112 | D | — | — | (F1) The restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversary of the grant date. |
| 4 | Common | Common Stock | 2023-02-23 | F | D | 2,421 | $31.90 | 176,918 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-02-22 | A | A | 143,156 | $0.00 | 143,156 | D | $28.86 · — to 2033-02-22 | 143,156 Common Stock | (F5) All stock options will vest on February 22, 2026. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-02-22 | A | A | 31,816 | $0.00 | 31,816 | D | $28.86 · — to 2033-02-22 | 31,816 Common Stock | (F4) The stock option will vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date. |